reported that the activation of the NOTCH pathway improved prognosis in HPV-negative HNSCC patients and suggested that NOTCH1 expression might be a predictive marker for survival in HPV-negative HNSCC (104). Here, NOTCH1 is linked to head and neck squamous cell carcinoma.